Effects of Lappaconitine Sulfate on Proliferation,Cycle and Apoptosis of Human Cerical Neoplasm Hela Cells
MA Jun-yi1,2, CHEN Xiang-ling1, HOU Chun-jing1, ZHU Jian-zhao1, HAN Xiao-fen1, ZHANG Ji1,2, GUO Hong-yun3
1. College of Life Science, Northwest Normal University, Lanzhou 730070, China; 2. Gansu Engineering and Technology Research Center of Effective Component Products from Characteristic Plants, Lanzhou 730070, China; 3. Gansu Provincial Academy of Medical Science, Lanzhou 730050, China
Abstract��OBJECTIVE To observe the effects of lappaconitine sulfate on proliferation, cycle and apoptosis of human cerical neoplasm Hela cells and its possible mechanism.METHODS Cell Counting Kit-8 (CCK-8) was adopted to observe the inhibitory effects of lappaconitine sulfate on the proliferation of Hela cells and calculated its half maximal inhibitory concentration (IC50). The technology of flow cytometry, propidium iodide (PI) single stained method and Annexin-V-FITC/PI double stained method were employed to measure the cell cycle and apoptosis of Hela cells after lappaconitine sulfate treatment.RESULTS Lappaconitine sulfate could inhibit the proliferation of human cerical neoplasm Hela cells in vitro, and the inhibition presented obvious dose-effect relationship (r=0.990 5, P��0.01). The IC50 of lappaconitine sulfate on Hela cells was 0.421 mg��mL-1. After dealt with lappaconitine sulfate, Hela cells indicated remarkable cell cycle arrest at G0/G1 phase, and the apoptotic ratio was gradually increased with the concentration of lappaconitine sulfate.CONCLUSION Lappaconitine sulfate could inhibit the growth of human cerical neoplasm Hela cells, change the distribution of cell cycles and induce their apoptosis.
�����, ������, ��, �콨��, ��С��, �ż�, ������. ������ڼ��ض��˹�����Helaϸ����ֳ�������������Ӱ��[J]. �й�ҩѧ��־, 2017, 52(12): 1038-1043.
MA Jun-yi, CHEN Xiang-ling, HOU Chun-jing, ZHU Jian-zhao, HAN Xiao-fen, ZHANG Ji, GUO Hong-yun. Effects of Lappaconitine Sulfate on Proliferation,Cycle and Apoptosis of Human Cerical Neoplasm Hela Cells. Chinese Pharmaceutical Journal, 2017, 52(12): 1038-1043.
WANG J L, SHEN X L, CHEN Q H, et al. Structure-analgesic activity relationship studies on the C18- and C19- diterpenoid alkaloids[J]. Chem Pharm Bull (Tokyo),2009, 57 (8):801- 807.
[2]
YU J Z, ZHANG B J, JIANG X T. Clinical application of lappaconitine hydrobromide[J]. J Second Mil Med Univ (�ڶ���ҽ��ѧѧ��), 2005, 26 (7):822-824.
[3]
OU S, ZHAO Y D, XIAO Z, et al. Effect of lappaconitine on neuropathic pain mediated by P2X3 receptor in rat dorsal root ganglion[J]. Neurochem Int, 2011, 58 (5):564-573.
[4]
WANG Y Z, XIAO Y Q, ZHANG C, et al. Study of analgesic and anti-inflammatory effects of lappaconitine gelata[J]. J Tradit Chin Med(��ҽ��־), 2009, 29 (2):141-145.
[5]
TOLSTIKOVA T G, BRYZGALOV A O, SOROKINA I V, et al. Solification with hydrobromic acid as a factor defining the antiarrhythmic effect of lappaconitine derivatives[J]. Letters Drug Design Discov, 2009, 6 (7):475-477.
[6]
WEI H B, ZHANG B H, TAN B, et al. Progress in studies of pharmacological activities and clinical applications of lappaconitine hydrobromide[J]. Chongqing Med (����ҽѧ), 2014, 43 (20):2660-2662.
[7]
SUN W X, WANG H, ZHANG S, et al. Crystal structure of lappaconitine-ium nitrate monohydrate, C32H47N3O12[J]. New Cryst Struct, 2014, 229 (4):485-487.
[8]
SUN W X, ZHANG S, WANG H, et al. Synthesis, characterization and antinociceptive properties of the lappaconitine salts[J]. Med Chem Res, 2015, 24 (9):3474-3482.
[9]
XIN R H, CHENG F S, HU Z Y, et al. Research situation of lappaconitine[J]. J Tradit Chin Veterin Med(����ҽҽҩ��־), 2009, 28 (2):74-76.
[10]
HU J M. Immunoregulatory effect of lappaconitine in S180 tumor-bearing mice[J]. J China Pharm(�й�ҩ��),2008, 19 (30):2343-2344.
[11]
LIN N, XIAO L Y, LIN P Y, et al. Experimental studies on antitumor effects of lappaconitine hydrobromide[J]. Tradit Chin Med Res(��ҽ�о�),2005, 18 (10):16-18.
[12]
WU Y H, NING Y Z, XU J B, et al. A study on Shenfu injection and lappaconitine hydrobromide injection inducing HL-60 differentiation and apoptosis[J]. J Guangzhou Univ Tradit Chin Med(������ҽҩ��ѧѧ��),2008, 25(2):231-237.
[13]
NING Y Z, TAN Y H, WU Y Y, et al. Effect of lappaconitine hydrobromide injection and Shenfu injection on the proliferation and apoptosis in murine hepatocarcinoma cell line H22[J]. Chin J Biochem Pharm(�й�����ҩ����־),2007, 28 (6):375-377.
[14]
LI E, CHEN X Y. Study on the effect of anticancer by acoitine on KBv200[J]. Chin J Inf Tradit Chin Med(�й���ҽҩ��Ϣ��־),2004, 11(2):103-105.
[15]
SOLYANIK G I,FEDORCHUK A G,PYASKOVSKAYA O N,et al. Anticancer activity of aconitine-containing herbal extract BC1[J]. Exp Oncol,2004,26(4):307-311.
[16]
GARNANCHOUK L V,PYASKOVSKAYA O N,YANISH Y V,et al. Influence of aconitine-containing herbal extract BC1 on proliferative and electrokinetic characteristics of endothelial cells[J]. Exp Oncol,2005, 27 (4):262-266.
[17]
SHENG L H, XU M, XU L Q, et al. Cytotoxic effect of lappaconitine on non-small cell lung cancer in vitro and its molecular mechanism[J]. J Chin Med Mater(��ҩ��),2014, 37 (5):840-843.
2017, Vol. 52 
